U.S. Department of Justice False Claims Act Update

You are subscribed to False Claims Act for U.S. Department of Justice. This information has recently been updated, and is now available.

Pfizer Agrees to Pay Nearly 60M to Resolve False Claims Allegations Relating to Improper Physician Payments by Subsidiary

01/24/2025 07:00 AM EST

Pharmaceutical company Pfizer Inc. (Pfizer), on behalf of its wholly-owned subsidiary Biohaven Pharmaceutical Holding Company Ltd. (Biohaven), has agreed to pay $59,746,277 to resolve allegations that, prior to Pfizer's acquisition of the company, Biohaven knowingly caused the submission of false claims to Medicare and other federal health care programs by paying kickbacks to health care providers to induce prescriptions of Biohaven's drug Nurtec ODT.

---

     

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy